These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 30563084)

  • 1. Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.
    Futsch N; Prates G; Mahieux R; Casseb J; Dutartre H
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
    Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
    Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
    Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
    Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
    Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
    Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
    Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.
    Chaves DG; Sales CC; de Cássia Gonçalves P; da Silva-Malta MC; Romanelli LC; Ribas JG; de Freitas Carneiro-Proietti AB; Martins ML
    J Med Virol; 2016 Aug; 88(8):1438-47. PubMed ID: 26800845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.
    Santos SB; Porto AF; Muniz AL; de Jesus AR; Magalhães E; Melo A; Dutra WO; Gollob KJ; Carvalho EM
    BMC Infect Dis; 2004 Mar; 4():7. PubMed ID: 15070424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators Go Together: High Production of CXCL9, CXCL10, IFN-γ, and TNF-α in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
    Neco HVPDC; Teixeira VGDS; da Trindade ACL; Magalhães PMR; de Lorena VMB; Castellano LRC; de Souza JR; Vasconcelos LR; de Moura PMMF; de Morais CNL
    AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1134-1139. PubMed ID: 28648091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.
    Sawada L; Nagano Y; Hasegawa A; Kanai H; Nogami K; Ito S; Sato T; Yamano Y; Tanaka Y; Masuda T; Kannagi M
    PLoS Pathog; 2017 Sep; 13(9):e1006597. PubMed ID: 28910419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
    J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
    Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
    Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Otaguiri KK; Dos Santos DF; Slavov SN; Depieri LV; Palma PVB; Meirelles FV; Covas DT; da Silveira JC; Kashima S
    AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1075-1082. PubMed ID: 30229663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
    Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
    Rizkallah G; Alais S; Futsch N; Tanaka Y; Journo C; Mahieux R; Dutartre H
    PLoS Pathog; 2017 Apr; 13(4):e1006353. PubMed ID: 28426803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.